Free Trial

Rafael (NYSE:RFL) Stock Rating Lowered by Wall Street Zen

Rafael logo with Medical background

Key Points

  • Rafael Holdings (NYSE:RFL) has been downgraded from a "hold" to a "sell" rating by Wall Street Zen.
  • The company's stock opened at $1.45 and has seen a 52-week low of $1.28 and a high of $3.19.
  • Rafael recently reported a loss of ($0.19) earnings per share and a negative return on equity of 24.75%.
  • Five stocks we like better than Rafael.

Rafael (NYSE:RFL - Get Free Report) was downgraded by investment analysts at Wall Street Zen from a "hold" rating to a "sell" rating in a research note issued to investors on Friday.

Rafael Trading Down 6.2%

Shares of RFL stock traded down $0.09 during trading hours on Friday, reaching $1.35. The company's stock had a trading volume of 264,420 shares, compared to its average volume of 81,435. The stock has a market capitalization of $47.37 million, a P/E ratio of -1.44 and a beta of 0.89. Rafael has a one year low of $1.28 and a one year high of $3.19. The firm's fifty day simple moving average is $1.77 and its 200 day simple moving average is $1.73.

Rafael (NYSE:RFL - Get Free Report) last issued its quarterly earnings data on Wednesday, June 11th. The company reported ($0.19) earnings per share for the quarter. The business had revenue of $0.36 million during the quarter. Rafael had a negative return on equity of 24.75% and a negative net margin of 3,127.60%.

Institutional Investors Weigh In On Rafael

A number of large investors have recently made changes to their positions in the business. Wealth Enhancement Advisory Services LLC bought a new stake in shares of Rafael during the first quarter valued at approximately $26,000. Ieq Capital LLC bought a new stake in shares of Rafael during the first quarter valued at approximately $447,000. Simplex Trading LLC bought a new stake in shares of Rafael during the second quarter valued at approximately $32,000. Americana Partners LLC bought a new stake in shares of Rafael during the second quarter valued at approximately $76,000. Finally, Geode Capital Management LLC boosted its holdings in Rafael by 72.9% in the second quarter. Geode Capital Management LLC now owns 451,139 shares of the company's stock worth $781,000 after acquiring an additional 190,179 shares in the last quarter. 11.30% of the stock is currently owned by institutional investors.

About Rafael

(Get Free Report)

Rafael Holdings, Inc primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. It operates in two segments, Healthcare and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells.

Featured Articles

Should You Invest $1,000 in Rafael Right Now?

Before you consider Rafael, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Rafael wasn't on the list.

While Rafael currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.